Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spacer peptide 1 (SP1) is a short peptide segment found within the Gag polyprotein of HIV-1, linking the capsid (CA) and nucleocapsid (NC) domains. SP1 is crucial for viral assembly and maturation, facilitating proper formation of infectious virions. It is a target for maturation inhibitors like bevirimat, which prevent cleavage at the CA-SP1 junction, leading to non-infectious virus particles. Mutations in SP1 can affect drug sensitivity.
Inhibition of CA-SP1 cleavage by HIV protease, resulting in non-infectious virions.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spacer Peptide 1 (None).